1. Home
  2. MAA vs ABVX Comparison

MAA vs ABVX Comparison

Compare MAA & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid-America Apartment Communities Inc.

MAA

Mid-America Apartment Communities Inc.

N/A

Current Price

$116.84

Market Cap

14.5B

Sector

Real Estate

ML Signal

N/A

Logo Abivax SA American

ABVX

Abivax SA American

N/A

Current Price

$87.87

Market Cap

11.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MAA
ABVX
Founded
1977
2013
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
11.9B
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
MAA
ABVX
Price
$116.84
$87.87
Analyst Decision
Hold
Strong Buy
Analyst Count
26
12
Target Price
$141.44
★ $164.00
AVG Volume (30 Days)
1.1M
★ 1.4M
Earning Date
10-28-2026
09-21-2026
Dividend Yield
★ 5.27%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.06
N/A
Revenue
★ $2,209,126,000.00
N/A
Revenue This Year
$0.88
N/A
Revenue Next Year
$2.45
$1,702.77
P/E Ratio
$109.61
★ N/A
Revenue Growth
★ 0.83
N/A
52 Week Low
$113.95
$69.81
52 Week High
$144.41
$148.83

Technical Indicators

Market Signals
Indicator
MAA
ABVX
Relative Strength Index (RSI) 38.19 32.10
Support Level N/A $74.79
Resistance Level $137.21 $128.68
Average True Range (ATR) 2.03 4.04
MACD 0.25 -0.38
Stochastic Oscillator 48.89 20.56

Price Performance

Historical Comparison
MAA
ABVX

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc is a multifamily-focused, self-administered and self-managed real estate investment trust. The company owns, operates, acquires and selectively develops apartment communities located in the Southeast, Southwest and Mid-Atlantic regions of the U.S. Its business objectives are to generate a sustainable, stable and increasing cash flow that will fund its dividends and distributions through all parts of the real estate investment cycle. It operates in two segments, Same Store and Non-Same Store and Other. The majority of the revenue is derived from Same Store segment.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: